(+)-VINCRISTINE
Enteropathy-Associated T-Cell Lymphoma
Eric Jacobsen, MDSmall moleculePhase 4 / ApprovedActive
BB
67/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 53/ 100
- Competitive Position
- 89/ 100
Competitive context
20 Active assets in the Enteropathy-Associated T-Cell Lymphoma cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
ETOPOSIDE Eric Jacobsen, MD | Phase 4 | BBB |
Inno-206 Eric Jacobsen, MD | Phase 4 | BBB |
Cyclophosphamide National Cancer Institute (NCI) | Phase 4 | BBB |
Ifosfamide Shandong Provincial Hospital | Phase 4 | BB |
PREDNISONE TABLETS Eric Jacobsen, MD | Phase 4 | BB |
View all 36 →
Same molecule, other indications
(+)-VINCRISTINE is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →